Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Digestive proteases are a diverse group of enzymes, including pepsin, trypsin, chymotrypsin, and elastase, that are essential for the breakdown of dietary proteins into absorbable amino acids and peptides (Wikipedia). Primarily secreted by the stomach and pancreas, these enzymes operate within the gastrointestinal tract to ensure proper nutrient acquisition and maintain metabolic homeostasis (NIH). Beyond their degradative roles, digestive proteases function as critical signaling molecules that interact with protease-activated receptors (PARs) to regulate intestinal permeability, motility, and immune responses (NIH). Clinically, they are most commonly utilized in pancreatic enzyme replacement therapy (PERT) for patients with exocrine pancreatic insufficiency (EPI) resulting from conditions such as cystic fibrosis or chronic pancreatitis (Drugs.com). Furthermore, the dysregulation of these enzymes is a key factor in the pathophysiology of gastrointestinal disorders like inflammatory bowel disease (IBD) and celiac disease, where they are being explored as both diagnostic biomarkers and therapeutic targets for inhibition or specific peptide degradation (NIH).
Digestive proteases catalyze the hydrolysis of peptide bonds within dietary proteins, breaking them down into smaller peptides and amino acids for absorption in the small intestine (Wikipedia). In therapeutic replacement, exogenous enzymes compensate for deficient endogenous production in conditions like exocrine pancreatic insufficiency (Drugs.com). In specific conditions like Celiac disease, engineered proteases degrade immunogenic peptides, such as gluten, to prevent immune activation (NIH). Additionally, these enzymes can act as signaling molecules by cleaving and activating protease-activated receptors (PARs) on the surface of intestinal cells, which modulates permeability and inflammation (NIH).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Digestive protease.